Antonini A - Search Results

1

Long-term intracerebral infusion of fibroblast growth factors restores motility and enhances F-DOPA uptake in parkinsonian monkeys.

de Yébenes JG, Pernaute RS, Garrido JM, Rábano A, Albisua J, Rojo A, Mena MA, Ruíz PG, Jorge P, Correa C, Leenders K, Antonini A, Gunther I, Psylla M, Vontobel P. de Yébenes JG, et al. Among authors: antonini a. Parkinsonism Relat Disord. 1998 Oct;4(3):147-58. doi: 10.1016/s1353-8020(98)00025-x. Parkinsonism Relat Disord. 1998. PMID: 18591105

2

Side effects of the catechol-O-methyl-transferase inhibitor Ro 40-7592 in rabbits.

Garrido JM, Mena MA, Correa C, Herraras O, Jorge P, Leenders K, Antonini A, Günther I, Psylla M, de Yébenes JG. Garrido JM, et al. Among authors: antonini a. Clin Neuropharmacol. 1994 Jun;17(3):270-6. doi: 10.1097/00002826-199406000-00006. Clin Neuropharmacol. 1994. PMID: 9316672

3

Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.

Antonini A, Vontobel P, Psylla M, Günther I, Maguire PR, Missimer J, Leenders KL. Antonini A, et al. Arch Neurol. 1995 Dec;52(12):1183-90. doi: 10.1001/archneur.1995.00540360061017. Arch Neurol. 1995. PMID: 7492293

4

Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and [11C]-raclopride.

Antonini A, Leenders KL. Antonini A, et al. Ann N Y Acad Sci. 1993 Sep 24;695:81-5. doi: 10.1111/j.1749-6632.1993.tb23033.x. Ann N Y Acad Sci. 1993. PMID: 8239318

5

Cerebral 6-[18F]fluoro-L-DOPA uptake in rhesus monkey: pharmacological influence of aromatic amino acid decarboxylase (AAAD) and catechol-O-methyltransferase (COMT) inhibition.

Psylla M, Günther I, Antonini A, Vontobel P, Reist HW, Zollinger A, Leenders KL. Psylla M, et al. Among authors: antonini a. Brain Res. 1997 Aug 29;767(1):45-54. doi: 10.1016/s0006-8993(97)00552-0. Brain Res. 1997. PMID: 9365014

6

D2 receptor binding in dopa-responsive dystonia.

Künig G, Leenders KL, Antonini A, Vontobel P, Weindl A, Meinck HM. Künig G, et al. Among authors: antonini a. Ann Neurol. 1998 Nov;44(5):758-62. doi: 10.1002/ana.410440509. Ann Neurol. 1998. PMID: 9818931

7

Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.

Antonini A, Leenders KL, Vontobel P, Maguire RP, Missimer J, Psylla M, Günther I. Antonini A, et al. Brain. 1997 Dec;120 ( Pt 12):2187-95. doi: 10.1093/brain/120.12.2187. Brain. 1997. PMID: 9448574

8

Benzodiazepine receptor binding in Huntington's disease: [11C]flumazenil uptake measured using positron emission tomography.

Künig G, Leenders KL, Sanchez-Pernaute R, Antonini A, Vontobel P, Verhagen A, Günther I. Künig G, et al. Among authors: antonini a. Ann Neurol. 2000 May;47(5):644-8. Ann Neurol. 2000. PMID: 10805336

9

Positron emission tomography in drug evaluation: influence of three different catechol-O-methyltransferase inhibitors on metabolism of [NCA] 6-[18F]fluoro-L-dopa in rhesus monkey.

Günther I, Psylla M, Reddy GN, Antonini A, Vontobel P, Reist HW, Zollinger A, Nickles RJ, Beer HF, Schubiger PA, et al. Günther I, et al. Among authors: antonini a. Nucl Med Biol. 1995 Oct;22(7):921-7. doi: 10.1016/0969-8051(95)00032-s. Nucl Med Biol. 1995. PMID: 8547890

10

Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.

Antonini A, Schwarz J, Oertel WH, Pogarell O, Leenders KL. Antonini A, et al. Mov Disord. 1997 Jan;12(1):33-8. doi: 10.1002/mds.870120107. Mov Disord. 1997. PMID: 8990051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

739 results

Search Page

Filters